Risk-Reduction Surgery Benefit in Non-BRCA Ovarian Cancer?
The Evolving Role of Risk-Reduction Surgery in Non-BRCA Gene Mutations As the landscape of genetic testing advances, so too does our understanding of cancer prevention, particularly for those with non-BRCA gene mutations. Recent research presented at the 2025 ANNALS of the USCAP reveals crucial insights into the efficacy of prophylactic surgeries beyond traditional BRCA1 and … Read more